Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Notice of Charter Renewal, 60168-60169 [2020-21035]
Download as PDF
<![CDATA[
60168
Federal Register / Vol. 85, No. 186 / Thursday, September 24, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meetings
Agency for Healthcare Research
and Quality (AHRQ), Health and Human
Services (HHS).
ACTION: Notice of five AHRQ
subcommittee meetings.
AGENCY:
The subcommittees listed
below are part of AHRQ’s Health
Services Research Initial Review Group
Committee. Grant applications are to be
reviewed and discussed at these
meetings. Each subcommittee meeting
will be closed to the public.
DATES: See below for dates of meetings:
1. Healthcare Safety and Quality
Improvement Research (HSQR)
Date: October 14th, 2020
2. Healthcare Effectiveness and
Outcomes Research (HEOR)
Date: October 14–15, 2020
3. Health Care Research and Training
(HCRT)
Date: October 15–16, 2020
4. Health System and Value Research
(HSVR)
Date: October 15–16, 2020
5. Healthcare Information Technology
Research (HITR)
Date: October 22–23, 2020
ADDRESSES: Agency for Healthcare
Research and Quality (Virtual Review),
5600 Fishers Lane, Rockville, Maryland
20857.
FOR FURTHER INFORMATION CONTACT: (To
obtain a roster of members, agenda or
minutes of the non-confidential portions
of the meetings.)
Jenny Griffith, Committee
Management Officer, Office of
Extramural Research Education and
Priority Populations, Agency for
Healthcare Research and Quality
(AHRQ), 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 27–
1557.
SUMMARY:
In
accordance with section 10(a)(2) of the
Federal Advisory Committee Act (5
U.S.C. App. 2), AHRQ announces
meetings of the above-listed scientific
peer review groups, which are
subcommittees of AHRQ’s Health
Services Research Initial Review Group
Committee. The subcommittee meetings
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2 section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). The grant applications and
the discussions could disclose
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:00 Sep 23, 2020
Jkt 250001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for these meetings are
subject to change as priorities dictate.
Dated: September 18, 2020.
Marquita Cullom-Stott,
Associate Director.
[FR Doc. 2020–21050 Filed 9–23–20; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Mine Safety and Health Research
Advisory Committee (MSHRAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Mine Safety and Health Research
Advisory Committee (MSHRAC). This is
a virtual meeting. It is open to the
public, limited only by web conference
lines (500 web conference lines are
available). If you wish to attend, please
contact Marie Chovanec by email at
MChovanec@cdc.gov or by telephone at
412–386–5302 at least 5 business days
in advance of the meeting. She will
provide you the Zoom web conference
access.
DATES: The meeting will be held on
November 9, 2020, from 10:00 a.m. to
2:30 p.m., EST.
ADDRESSES: This is a virtual meeting.
FOR FURTHER INFORMATION CONTACT:
George W. Luxbacher, Designated
Federal Officer, MSHRAC, NIOSH, CDC,
2400 Century Parkway NE, Atlanta, GA
30345, telephone 404–498–2808; email
gluxbacher@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This committee is charged
with providing advice to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NIOSH, on priorities in mine
safety and health research, including
grants and contracts for such research,
30 U.S.C. 812(b)(2), Section 102(b)(2).
Matters To Be Considered: The agenda
will include discussions on mining
safety and health research projects and
outcomes, including COVID–19 impact
SUMMARY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
on research, funded projects,
presentations, guidelines; Office of Mine
Safety and Health Research (OMSHR)
reshaping status; FY21 new mining
projects and redesigning research;
lighting research; update on MINER Act
extramural research; and mining-related
suicides. The meeting will also include
an update from the NIOSH Associate
Director for Mining. Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–21034 Filed 9–23–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP); Notice of
Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP),
Centers for Disease Control and
Prevention, Department of Health and
Human Services, has been renewed for
a 2-year period through September 18,
2022.
FOR FURTHER INFORMATION CONTACT:
Moises C. Langub, Ph.D., Designated
Federal Officer, CDC, 1600 Clifton Road
NE, Mailstop TW–2, Atlanta, Georgia
30329–4027, telephone (770) 488–3585;
email MLangub@cdc.gov.
SUPPLEMENTARY INFORMATION: The
Director, Strategic Business Initiatives
Unit, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
SUMMARY:
E:\FR\FM\24SEN1.SGM
24SEN1
Federal Register / Vol. 85, No. 186 / Thursday, September 24, 2020 / Notices
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–21035 Filed 9–23–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–8003, CMS–
10633, CMS–10116, CMS–319, and CMS–
10540]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by October 26, 2020.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
DATES:
VerDate Sep<11>2014
17:00 Sep 23, 2020
Jkt 250001
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Reinstatement with change of a
previously approved collection; Title of
Information Collection: 1915(c) Home
and Community Based Services (HCBS)
Waiver Application; Use: We will use
the web-based application to review and
adjudicate individual waiver actions.
The web-based application will also be
used by states to submit and revise their
waiver requests. Form Number: CMS–
8003 (OMB control number 0938–0449);
Frequency: Yearly; Affected Public:
State, Local, or Tribal Governments;
Number of Respondents: 47; Total
Annual Responses: 71; Total Annual
Hours: 6,005. (For policy questions
regarding this collection contact Kathy
Poisal at 410–786–5940.)
2. Type of Information Collection
Request: Revision with change of a
currently approved collection; Title of
Information Collection: QIC
Demonstration Evaluation Contractor
(QDEC): Analyze Medicare Appeals to
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
60169
Conduct Formal Discussions and
Reopenings with DME Suppliers and
Part A Providers; Use: The Formal
Telephone Discussion Demonstration
and Reopenings Process is authorized
under Section 402(a)(1)(F), U.S.C. 1395–
1(a)(1)(F), of the Social Security
Amendments of 1967. Primary and
secondary data are needed to
understand the effectiveness of the
Demonstration in improving DME
suppliers’ and Part A providers’
understanding of claims denial during
Level 2 of the appeals process and
facilitating more accurate claim
submission over time. Primary data are
necessary to determine, from the
perspective of participating DME
suppliers and Part A providers, the
quality of the formal telephone
discussions, satisfaction with the formal
telephone discussion process, and the
effect of the formal telephone
discussions on submitting accurate
claims. These data will inform an
evaluation of the demonstration’s
effectiveness in achieving more accurate
claims submissions, and thus reducing
the number of claims CMS must process
each year.
All information collected through the
evaluation of the Formal Telephone
Demonstration and Reopenings Process
will be used by CMS through the QDEC
(IMPAQ International and its partner,
Palmetto GBA) to conduct analyses of
satisfaction with the formal telephone
discussions, and determine whether
further engagement with the QIC
improves understanding of the reasons
for claim denials.
CMS will use the results of the
evaluation to make informed policy
decisions regarding the effectiveness of
this demonstration and whether or not
the demonstration should become a
permanent part of the appeals process.
Ultimately, if the information shows
that DME suppliers and Part A
providers were able to submit more
accurate claims on the first pass, and a
reduced number of claims are put
through the appeals process, the Federal
government could realize cost savings.
Form Number: CMS–10633 (OMB
control number: 0938–1348); Frequency:
Yearly; Affected Public: Private Sector,
Business or other for-profits; Number of
Respondents: 5,288; Total Annual
Responses: 5,288; Total Annual Hours:
950. (For policy questions regarding this
collection contact Lynnsie G. Kelley at
410–786–1155.)
3. Type of Information Collection
Request: Reinstatement without change
of a previously approved collection;
Title of Information Collection:
Medicare Program: Conditions for
Payment of Power Mobility Devices,
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 85, Number 186 (Thursday, September 24, 2020)]
[Notices]
[Pages 60168-60169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21035]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP); Notice of Charter Renewal
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of charter renewal.
-----------------------------------------------------------------------
SUMMARY: This gives notice under the Federal Advisory Committee Act of
October 6, 1972, that the Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP), Centers for Disease Control
and Prevention, Department of Health and Human Services, has been
renewed for a 2-year period through September 18, 2022.
FOR FURTHER INFORMATION CONTACT: Moises C. Langub, Ph.D., Designated
Federal Officer, CDC, 1600 Clifton Road NE, Mailstop TW-2, Atlanta,
Georgia 30329-4027, telephone (770) 488-3585; email [email protected].
SUPPLEMENTARY INFORMATION: The Director, Strategic Business Initiatives
Unit, Office of the Chief Operating Officer, Centers for Disease
Control and Prevention, has been delegated the authority to sign
Federal Register notices pertaining to announcements of
[[Page 60169]]
meetings and other committee management activities, for both the
Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-21035 Filed 9-23-20; 8:45 am]
BILLING CODE 4163-18-P
